• OPEN AN ACCOUNT
Indian Indices
Nifty
24,973.10 104.50
(0.42%)
Sensex
81,425.15 323.83
( 0.40%)
Bank Nifty
54,536.00 319.90
( 0.59%)
Nifty IT
36,183.80 927.90
( 2.63%)
Global Indices
Nasdaq
45,729.90 193.94
(0.43%)
Dow Jones
6,533.40 17.25
(0.26%)
Hang Seng
43,788.68 329.39
(0.76%)
Nikkei 225
9,242.53 21.09
(0.23%)
Forex
USD-INR
88.02 -0.16
(-0.18%)
EUR-INR
103.30 -0.01
(-0.01%)
GBP-INR
119.05 -0.02
(-0.01%)
JPY-INR
0.60 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
299.4743419
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.75
603.76
EPS(TTM)
Face Value()
Div & Yield %
49.65
10
0.05
 

As on: Sep 10, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,251.70 -27.00 15502 25.75
Stock Price Details
Open Price() 1,227.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,275.00
Today's Low () 1,214.80
52-Week High () 1340
152-Week Low () 635
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.05
Eps 49.65
Book Value 299.4743419
Market Cap (.Cr) 603.76
Face Value 10
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE194R01017


News
Fredun Pharmaceuticals standalone net profit rises 63.92% in the June 2025 quarter
Fredun Pharmaceuticals to convene board meeting
Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Demise
Fredun Pharmaceuticals standalone net profit rises 39.72% in the March 2025 quarter
Fredun Pharmaceuticals Ltd - Investor Presentation Of Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Ltd - Investors Presentation Issued By Fredun Pharmaceuticals Limited Stating Annual Review & Strategic Outlook For Growth In The Pharma Industry
Board of Fredun Pharmaceuticals recommends final dividend
Fredun Pharmaceuticals Ltd - Compliances-Reg.24(A)-Annual Secretarial Compliance
Fredun Pharmaceuticals declare Quarterly Result
Fredun wins order from Tamil Nadu Medical Services Corporation
More
Corporate Details
Incoporation Year   : 1987
Chairman : Daulat N Medhora
Bussiness Group :
Registered Office
Fredun Pharmaceuticals Ltd
26 Manoj Industrial Premises,
G D Ambedkar Marg Wadala,
Mumbai,
Maharashtra-400031
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40318111
Fax:N.A.
Fax:91-22-66317458
E-Mail : business@fredungroup.com
URL : http://www.fredungroup.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi